Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00228514
NCT00228514CompletedPhase 3

Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) PET Sub Study

AstraZeneca1 site in 1 country40 target enrollmentStarted: February 2004Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
40
Locations
1
Primary Endpoint
To study the effect of rosuvastatin in Chronic Heart Failure on myocardial perfusion (reserve). Before and 6 months after study medication is started a Positron Emission Tomography (PET-scan) is performed.
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

At one site, patients participating in the Corona main study are asked to participate in the PET-substudy. Before and 6 months after study medication is started a Positron Emission Tomography (PET-scan) is performed to study the effect of rosuvastatin in Chronic Heart Failure on myocardial perfusion (reserve)

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double

Eligibility Criteria

Ages
60 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients fulfilling the in and exclusion criteria of the CORONA study and separate informed consent for participation in the sub study.

Exclusion Criteria

  • •See above

Outcomes

Primary Outcomes

To study the effect of rosuvastatin in Chronic Heart Failure on myocardial perfusion (reserve). Before and 6 months after study medication is started a Positron Emission Tomography (PET-scan) is performed.

Secondary Outcomes

  • To study the effect of rosuvastatin in Chronic Heart Failure on mismatch. Before and 6 months after study medication is started a Positron Emission Tomography (PET-scan) is performed.

Investigators

Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 3
Crestor Versus Placebo in Subjects With Heart FailureHeart Failure
NCT00206310AstraZeneca5,013
Completed
Phase 2
Glenohumeral Cortisone InjectionHumeral Fractures
NCT04216017University of Washington9
Completed
Phase 2
Exemestane or Docetaxel-Cytoxan in Low Recurrence Score CancersBreast Cancer
NCT00941330Emory University31
Unknown
Phase 4
Study of Statin for Reduction of Postoperative Paroxysmal Atrial FibrillationParoxysmal Atrial Fibrillation
NCT02502110The Third Xiangya Hospital of Central South University346
Unknown
Not Applicable
Peking and Rotterdam on Mission to Reduce Coronary Artery DiseaseDiabetes MellitusAcute Coronary Syndrome
NCT01653119Peking University Third Hospital1,000